LinqMed Inc.

Program name

Deep-Tech Startups Support Program

Research theme

Development of the drug discovery platform based on 64Cu to expedite the R&D of new-generation drugs

Business Plan

In this project, a large-scale production of 64Cu will be developed. 64Cu is a unique radioisotope that emits radiation for diagnostic and therapeutic purposes and that easily binds to a variety of molecules. This project will establish Japan's original drug discovery support platform that can rapidly develop "visible" cancer treatments using 64Cu as new-generation drugs. This platform will create a new fundamental for the drug industry.

Research Outline

During this project period, we will collaborate with some companies to establish a drug discovery support platform based on 64Cu. Through this, we will develop a large-scale RI production technology that will take on the challenge of creating the next generation pharmaceutical industry infrastructure, and aim to solve economic and social issues.

(1) Establishment of a large-scale production technology of 64Cu

(2) Establishment of manufacturing technology for 64Cu with high specific radioactivity

(3) Long-term stabilization of 64Cu pharmaceuticals

• Download this page（189KB）